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Cytochromec (CC)-initiatedApaf-1apoptosome
formation represents a key initiating event in
apoptosis. This process can be reconstituted
in vitro with the addition of CC and ATP or
dATP to cell lysates. How physiological levels
of nucleotides, normally at high mM concentra-
tions, affect apoptosome activation remains
unclear. Here we show that physiological levels
of nucleotides inhibit the CC-initiated apopto-
some formation and caspase-9 activation by
directly binding to CC on several key lysine
residues and thus preventing CC interaction
with Apaf-1. We show that in various apoptotic
systems caspase activation is preceded or
accompanied by decreases in overall intracellu-
lar NTP pools. Microinjection of nucleotides
inhibits whereas experimentally reducing NTP
pools enhances both CC and apoptotic stim-
uli-induced cell death. Our results thus suggest
that the intracellular nucleotides represent criti-
cal prosurvival factors by functioning as natural
inhibitorsofapoptosomeformationandabarrier
that cells must overcome the nucleotide barrier
to undergo apoptosis cell death.
INTRODUCTION
Activation of the initiator caspases represents the key
event in the apoptotic process. Different from the effector
caspase activation, the intrachain cleavage only modestly
enhances the catalytic activities of the initiator caspases.Rather, initiator caspase activation involves adaptor pro-
tein-mediated oligomerization. For example, caspase-8
activation involves FADD-mediated recruitment of pro-
caspase-8 to plasma membrane death receptors resulting
in proximity-induced dimerization and autocatalytic acti-
vation (Boatright et al., 2003). Likewise, caspase-9 activa-
tion requires the adaptor protein Apaf-1 (Jiang and Wang,
2004). Various intrinsic death stimuli compromise the
integrity of the mitochondria and cause the release of
cytochrome c (CC) into the cytoplasm. CC then binds to
and induces oligomerization of Apaf-1 to form the ‘‘apop-
tosome,’’ a heptameric complex with molecular masses of
700–1400 kDa (Cain et al., 2000; Li et al., 1997; Zou et al.,
1999), leading to activation of procaspase-9.
Elegant studies by Wang and colleagues, using cell-free
or recombinant protein reconstitution experiments, were
the first to reveal a critical requirement for ATP or dATP
[(d)ATP] in the CC-initiated apoptosome activation in vitro
(Jiang and Wang, 2000; Li et al., 1997; Liu et al., 1996).
Recent work demonstrates that Apaf-591, which lacks
the WD-40 repeats but retains the nucleotide and oligo-
merization domain (NOD), contains a tightly bound ADP
molecule (Riedl et al., 2005). Structural studies suggest
that this prebound ADP molecule may play an essential
function in coordinating different Apaf-1 domains and
keeping Apaf-1 conformationally inactive (Riedl et al.,
2005). More recent work reveals that the full-length
Apaf-1 has one molecule of dATP bound, and CC binding
to Apaf-1 appears to induce hydrolysis of dATP to dADP,
which subsequently exchanges for exogenous dATP to
initiate apoptosome assembly (Kim et al., 2005; Yu et al.,
2005). Thus, CC binding to Apaf-1 represents the most
apical and critical event in apoptosome formation and
caspase activation.
In cell-free reconstitution experiments, mM to low-mM
concentrations of (d)ATP are added to cell lysates,Cell 125, 1333–1346, June 30, 2006 ª2006 Elsevier Inc. 1333
together with CC, to initiate caspase-9 activation (Cain
et al., 2000; Liu et al., 1996; Zou et al., 1999). Most mam-
malian cells, however, have an intracellular ATP and nu-
cleotide pool at high-mM concentrations (e.g., Craig and
Wallace, 1991; Miller and Horowitz, 1986; Mesner et al.,
1999). Therefore, it is unclear how physiological levels of
nucleotides affect CC-initiated caspase activation in vivo
(i.e., in the cells). Here we show that intracellular nucleo-
tides as well as many nucleotide derivatives exert a strong
inhibitory effect on the CC-initiated apoptosome forma-
tion by directly binding to CC and inhibiting the interaction
of CC with Apaf-1. As microinjection of nucleotides
inhibits whereas experimentally reducing NTP pools en-
hances both CC and apoptotic stimuli-induced cell death,
our results suggest that nucleotides and nucleotide deriv-
atives, in addition to their well-established roles in nucleic
acid synthesis, energy metabolism, biosynthesis regula-
tion, and signal transduction, also function as physiologi-
cal prosurvival factors.
RESULTS
CC Initiates Caspase Activation in Fresh Cytosol
without a Requirement for Exogenous Nucleotides
To determine the effects of intracellular nucleotides on
caspase activation, we isolated fresh cytosol (S100)
from GM701 human fibroblasts. Addition of CC, without
exogenous (d)ATP, to the fresh cytosol initiated a time-
dependent processing of procaspase-9 to p35/37 and
procaspase-3 to p24/20/17, along with the expected
increases in enzymatic activity (Figures 1A and 1B). Simi-
lar results were obtained from various cancer and primary
cells (Figure S1). Since (d)ATP is essential for the CC-initi-
ated apoptosome formation and caspase activation in
cell-free reconstitution experiments (Jiang and Wang,
2000; Li et al., 1997), the above results suggest that freshly
purified cytosols may contain sufficient amounts of nucle-
otides to assist in the CC-initiated caspase activation.
Indeed, direct measurements of (d)NTP levels in six tumor
cell lines and three primary cell strains revealed that these
cells had ATP levels of 1.5–5 mM, and they possessed an
NTP pool of 3–7 mM and a dNTP pool of 10–80 mM
(Table S1).
Exogenous Nucleotides and Nucleotide
Intermediates Inhibit CC-Dependent
Caspase Activation
Most surprisingly, when we added different amounts of
dATP, together with CC, to the fresh cytosol, we observed
a dose-dependent inhibitory effect of dATP on the CC-ini-
tiated caspase activation. Western blot (Figure 1C) and
caspase activity (Figure 1D) revealed that the inhibition
occurred at 1 mM, became obvious at 2 mM, and was
complete at 5 mM. Similar inhibitory effects of dATP
were observed using cytosols freshly prepared from vari-
ous cancer or primary cells (Figure S1).
Other nucleotides such as ATP also inhibited CC-
initiated caspase activation (Figures 1E and 1F). Like1334 Cell 125, 1333–1346, June 30, 2006 ª2006 Elsevier Inc.(d)ATP, all other (d)NTPs [(deoxy)ribonucleotide triphos-
phates; see Figure S2 for general structures] also demon-
strated inhibitory effects on the CC-initiated caspase
activation (Figures 1G and S3A). The inhibitory effects of
(d)ATP were unlikely due to Na+ salts (Cain et al., 2001)
contained in the nucleotide preparations, as their Tris
forms demonstrated equipotent effects (Figure S3B).
Moreover, pure NaCl did not exert an inhibitory effect until
75–150 mM (Figure S3B, lane 13; data not shown). Pooled
nucleotides comprising equimolar concentrations of indi-
vidual nucleotides similarly showed a dose-dependent
inhibition on the CC-initiated caspase activation (Fig-
ure S3C). The inhibitory effects of (d)NTPs were indepen-
dent of hydrolysis of phosphodiester bonds as three
nonhydrolyzable analogs (ATPgS, AMP-PCP, and AMP-
PNP) inhibited caspase-9 and -3 processing as efficiently
as (d)ATP (Figure 1H, lanes 4–6 versus lane 3). All (d)NDPs
[(deoxy)ribonucleotide diphosphates] except for dADP
and dGDP also inhibited the CC-initiated caspase activa-
tion (Figures 1H and S3A, data not shown). dADP and
dGDP did show an inhibitory effect but only at higher
(10 mM) concentrations (not shown). By contrast, none
of the (d)NMPs [(deoxy)ribonucleotide monophosphates]
demonstrated any inhibitory effect (Figure 1H).
Apart from (d)NTPs or (d)NDPs, the major coenzymes,
NAD, NADP, FAD, Co-A, nucleotide analogs, and phos-
phoribosyl pyrophosphate (PRPP; the most important
precursor to nucleotide synthesis), all showed inhibitory
effects (Figures S2, S3D, and S3F). By contrast, several
abundant nucleotide intermediates such as UDP-glucose
(precursor of glycogen), CDP-diacylglycerol (CDP-DG;
precursor of phosphoglycerides), S-adenosylmethionine
(SAM; activated methyl-group donor), nucleoside ana-
logs, D- or L-ribose, and ribose-phosphate did not show
any inhibitory effect (Figures S2, S3D, S3E, and S3F).
Nucleotides Inhibit CC-Apaf-1 Interaction, Apaf-1
Oligomerization, and Apoptosome Formation
Caspase-9 activation involves Apaf-1 oligomerization/
apoptosome formation followed by sequential recruitment
and activation of caspase-9 and -3 (Bratton et al., 2001).
To determine at which step nucleotides exert the inhibitory
effect, we preincubated fresh cytosol with CC for different
periods of time and then added dATP. The inhibitory
effects of dATP on caspase-9 and -3 processing were
progressively lost when dATP was added later in time
(Figure 2A). By contrast, coaddition of CC and dATP
(5 mM), or preaddition of dATP followed by CC addition
to the cytosol, completely inhibited the CC-initiated cas-
pase processing (not shown).
Since IAPs, and in particular, XIAP, bind to and inhibit
caspase activity, we immunodepleted the fresh GM701
cytosol of XIAP (Figure 2B) and then used it in reconstitu-
tion experiments. We observed that ATP similarly inhibited
the CC-induced caspase processing (Figure 2C). Since
IAPs other than XIAP also bind to active caspases and
inhibit their activity, we included in the reaction mixture
the recombinant, functionally active Smac protein, which
Figure 1. Inhibition of the CC-Initiated Caspase Activation by Multiple Nucleotides
(A and B) Fresh GM701 cytosol (250 mg) was incubated with CC for the time periods indicated. At the end, Western blotting for caspase-9 and -3 (A)
and caspase activity measurements (B) were performed.
(C and D) Fresh GM701 cytosol incubated with CC in the absence or presence of various amounts of dATP was used in Western blotting (C) or cas-
pase activity measurement (D).
(E–H) Fresh GM701 cytosol incubated with CC in the presence of ATP (E and F), dNTPs (G), or 5 mM of (d)NDPs, (d)NMPs, or nonhydrolyzable analogs
(H). Western blotting and caspase activity measurements were performed at the end. Abbreviations: ATPgS, adenylyl-50-O-(3-thiotriphosphate); PCP
(AMPPCP), 50-adenylyl methylenediphosphate; PNP (AMPPNP), 50-adenylyl imidodiphosphate. Caspase activities (B, D, and F) were presented as
values (mean ± SD from two to three independent experiments) relative to the control. *, a nonspecific band (C, E, G, and H), is shown.Cell 125, 1333–1346, June 30, 2006 ª2006 Elsevier Inc. 1335
Figure 2. Nucleotides Directly Inhibit CC-Apaf-1 Interaction
(A) Fresh GM701 cytosol was incubated with CC in the absence of dATP (lane 2) or the cytosol was coincubated with CC for the time periods indicated
before adding dATP (5 mM).
(B and C) Fresh GM701 cytosol was depleted of XIAP (B; cyto and S refer to undepleted and depleted cytosol, respectively) and this XIAP-depleted
cytosol was then incubated with CC in the absence (lane 2) or presence of various amounts of ATP (C).
(D) Fresh GM701 cytosol was incubated alone (lane 1), with CC (lane 2), CC plus Smac (lane 3), or with CC plus Smac in the presence of ATP (lanes 4–7).
(E–I) Fresh GM701 cytosol was incubated with CC alone or CC plus dATP (5 mM) for 10 min at 37ºC and then used in IP with antibody to CC (E),
caspase-9 (casp-9; F), Apaf-1 (G), or Rb IgG (H). In (I), the cytosol was coincubated for 1 hr at 37ºC and then used in IP with anti-Apaf-1 antibody.
Western blotting was performed for the molecules indicated at the end.relieves the caspase inhibitory effects of all IAPs. As
shown in Figure 2D, Smac did not affect the inhibitory effect
of ATP on the CC-initiated caspase-9 and -3 processing.
These results (Figures 2A–2D) suggest that the inhibi-
tory effect of nucleotides is not mediated through IAPs
but rather through direct interference of apoptosome
formation/function. To test this possibility, we carried out1336 Cell 125, 1333–1346, June 30, 2006 ª2006 Elsevier Inc.coimmunoprecipitation (co-IP) experiments in the pres-
ence or absence of dATP. The anti-CC antibody pulled
down nearly all Apaf-1 in the absence of dATP (Figure 2E).
By contrast, in the presence of inhibitory concentrations of
dATP, much less Apaf-1 was coprecipitated by anti-CC
antibody (Figure 2E, lanes 4 and 5). The anti-CC antibody
did not pull down caspase-9 or caspase-3 (Figure 2E).
Figure 3. Nucleotides Inhibit Apopto-
some Formation and Function
Control GM701 cytosol (upper), cytosol coin-
cubated with CC alone (middle), or cytosol
coincubated with CC plus dATP (5 mM), all
750 mg, were fractionated on a Superose 6
HR 10/30 column. An aliquot of each fraction
was analyzed by Western blotting for Apaf-1,
caspase-9, and caspase-3 (A) or used to deter-
mine the DEVDase activity (B). For caspase
processing activity (CPA), 50 ml of fractions
7–17 was incubated with recombinant procas-
pase-3 (300 nM) for 1 hr followed by DEVDase
activity measurement. DEVDase and CPA
activities are presented as arbitrary unit.Co-IP using anti-caspase-9 antibody precipitated Apaf-1
from the CC-activated cytosol but little Apaf-1 was precip-
itated down in the presence of dATP (Figure 2F). The
anti-caspase-9 antibody did not pull down caspase-3
(Figure 2F), as previously shown (Bratton et al., 2001).
Reciprocal co-IP with anti-Apaf-1 antibody pulled down
caspase-9 in the absence of dATP but not in its presence
(Figure 2G). As expected, the Apaf-1 antibody did not
bring down caspase-3 (Figure 2G) and the control anti-
body, Rb IgG, did not precipitate any molecule (Figure 2H).
Finally, Apaf-1 IP, using cytosol that had been subjected
to 1 hr preincubation with CC, coprecipitated processed
caspase-9 (p37/35) as well as processed caspase-3
(p20) in the absence but not in the presence of dATP
(Figure 2I).
If 5 mM dATP inhibits the CC interaction with Apaf-1, it
should also inhibit Apaf-1 oligomerization, which was
revealed by Superose 6 gel filtration chromatography
experiments (Figure 3A). In control cytosol, Apaf-1 eluted
as monomeric protein with a relative molecular mass of
158 kDa and procaspase-9 and -3 eluted as unpro-cessed zymogens (Figure 3A). In the CC-activated cyto-
sol, most of the Apaf-1 eluted as an 700 kDa complex
and procaspase-9 was completely processed to p37/35,
which were associated with the complex or as the free
processed form (Figure 3A). Caspase-processing activity
(CPA) of the 700 kDa apoptosome complex (Figure 3B,
fractions 10–15) also demonstrated its functional activity.
The processed caspase-3 (p20/17) eluted mostly as free
form (Figure 3A), which coeluted with all the DEVDase
activity (Figure 3B). Presence of dATP (5 mM) in the CC-
activated cytosol completely prevented formation of the
700 kDa oligomeric active Apaf-1 complex and caspase
processing and activation (Figures 3A and 3B).
To provide the most direct evidence that high concen-
trations of nucleotides inhibit the CC-Apaf-1 interaction
and subsequent Apaf-1 oligomerization, we used the
baculovirus expression system to generate recombinant
Apaf-1 XL (Apaf-1 for short), which has additional WD-40
repeats and is highly active in initiating apoptosome for-
mation (Benedict et al., 2000). Far Western analysis
showed that 5 mM ATP directly inhibited CC binding toCell 125, 1333–1346, June 30, 2006 ª2006 Elsevier Inc. 1337
recombinant Apaf-1 immobilized on the PVDF membrane
(Figure 4A).
Subsequently, we carried out reconstitution experi-
ments using recombinant Apaf-1 and in vitro-translated
(IVT), 35S-labeled procaspase-9. Coincubation of Apaf-1,
procaspase-9, and CC in the absence of nucleotides did
not result in caspase-9 processing (Figure 4B, lane 1; Fig-
ure 4C, lane 3). Inclusion of 0.5–1 mM of dATP (Figure 4B,
lane 2; Figure 4C, lanes 4 and 5) or ATP (Figure 4C, lane 9),
but not dGTP (Figure 4C, lane 13), GTP (Figure 4C, lane
18), or other nucleotides (not shown), in the reaction led
to caspase-9 processing. However, increasing amounts
of dATP (Figure 4C, lanes 6–8), ATP (lanes 10–12), dGTP
(lanes 15–17), or GTP (lanes 20–22) clearly inhibited CC/
Apaf-1/dATP-mediated processing of caspase-9. Simi-
larly, other nucleotides such as dADP (Figure 4B, lanes
12–14), ADP (Figure 4B, lanes 15 and 16), nucleotide inter-
mediates such as ADP-ribose (Figure 4B, lanes 3–6), and
nucleotide analogs such as 8-NH2-ATP and 2-Cl-ATP
(Figure 4B, lanes 17–20) also inhibited apoptosome-
induced caspase-9 activation at higher concentrations.
Interestingly, cyclic ADP-ribose (Figure S2P) did not inhibit
caspase-9 processing (Figure 4B, lanes 7–10). To deter-
mine whether the inhibition of apoptosome-mediated cas-
pase-9 processing, in this pure recombinant system, was
associated with hindrance in Apaf-1 oligomerization or in-
hibition of caspase-9 autoprocessing, we evaluated the
CC-induced Apaf-1 oligomerization in the presence of
a low versus high concentration of ATP. As shown in Fig-
ure 4D, although 0.5 mM ATP induced robust Apaf-1 olig-
omerization leading to the formation of 700 kDa active
apoptosome complex, 5 mM ATP abrogated the CC-initi-
ated Apaf-1 oligomerization.
Nucleotides Directly Bind to CC: Critical Roles
of Lysine Residues
It is well known that CC interaction with its natural redox
partners in the respiratory chain (i.e., CC reductase and
CC oxidase) involves electrostatic interactions. Therefore,
it was possible that physiological levels of nucleotides
might directly bind CC via electrostatic interactions and
consequently prevent CC from binding to Apaf-1. If this
were the case, nucleotides should not demonstrate signif-
icant inhibitory effects on caspase activation initiated by
an Apaf-1 mutant that does not bind CC but still retains
the ability to activate caspase-9. We tested this postulate
by using Apaf-543 (i.e., the aa 1–543 fragment; courtesy of
S. Kornbluth), an Apaf-1 mutant that lacks the WD-40
domain. As shown in Figure S4A, the Apaf-543 (but not
Apaf-1 CARD domain) initiated caspase-9 activation with-
out requiring CC, consistent with earlier observations
(Srinivasula et al., 1998). Remarkably, ATP at up to
10 mM only slightly inhibited the caspase-9 activation ini-
tiated by Apaf-543 (Figure S4A).
To prospectively identify the potential amino acid
residues on the CC that mediate nucleotide binding, we
employed the sensitive matrix-assisted laser desorption/
ionization mass spectrometry (MALDI-MS) approach.1338 Cell 125, 1333–1346, June 30, 2006 ª2006 Elsevier Inc.The results revealed a concentration-dependent increase
in ATP (mass = 506 ± 4 Da) binding to CC (12,231 Da),
with 1–3 ATP molecules (CC + 1 ATP ligand = 12,737 ±
5 Da) binding at 10–100 mM (Figures 5B and 5C), up to 5
ATP molecules binding at 0.5–1 mM (Figures 5D and
S4C), and 5–7 ATP molecules binding at 2–5 mM
(Figure 5E; data not shown). The complex formed between
CC and ATP was due to noncovalent interactions as no li-
gand binding was observed following desalting of the sam-
ple on a protein trap and column followed by ESI-MS anal-
ysis (not shown). Peptide mapping and LC-MS/MS using
photoaffinity probe 8-azido-ATP revealed 11 sites with
a +28 Da modification at presumed ATP binding sites (Table
S2). These were K7, K8, K13, K25, K27, K39, K72, K73, K86,
K87, and K88 (Table S2 and Figure 5F), which represent 11
of the 18 lysine (K) residues in CC.
Similar to ATP, 2 mM of CTP (not shown), dATP (Fig-
ure S4D), NTP pool (Figure S4E), dNTP pool (Figure S4F),
and NADP (not shown) also demonstrated binding to CC.
In contrast to ATP and other nucleotides, 2 mM of ADP
and AMP demonstrated much reduced or no binding to
CC (Figures 5G and 5H). To directly test the relationship
between ATP binding to CC and CC-mediated caspase
activation, we preincubated CC with 2 or 5 mM ATP and
then removed the unbound ATP through dialysis. As
shown in Figure 5I, CC prebound with ATP failed to acti-
vate Apaf-1-mediated caspase-9 cleavage (lanes 6–8).
Four of the eleven K residues identified (i.e., K7, K25, K39,
and K72) have previously been shown to be involved in CC-
Apaf-1 interaction (Figure 5F; Yu et al., 2001), suggesting
that nucleotide binding to these K residues will interfere
with CC binding to Apaf-1. Structural modeling revealed
that three other potential ATP binding sites on CC, i.e.,
K8, K27, and K73, were in the immediate vicinity of K7,
K25, and K72, respectively (Figure 5F), suggesting that nu-
cleotide binding to these K residues will likely also interfere
with CC-Apaf-1 interactions. Indeed, prospective mutation
of K8 into Ala (K8A) abolished the ability of CC to activate
the Apaf-1-mediated caspase-9 activation (Figure S4B). In
contrast, the wild-type CC induced robust caspase-9 acti-
vation that was inhibited, as expected, by increasing
amounts of ATP (Figure S4B, lanes 2–6). The other four K
residues identified, i.e., K13, K86, K87, and K88 (Figure 5F),
had not been studied with respect to their importance in
CC-Apaf-1 interaction. Therefore, we carried out site-spe-
cific mutagenesis on wild-type human CC to create K13A,
K86A, K87A, K88A, K86A/K87A, and K86A/K87A/K88A
mutants. The results revealed that all these individual
and compound mutant CC proteins failed to activate the
Apaf-1-mediated caspase-9 activation (Figure S4B).
Intracellular Nucleotides as Critical Prosurvival
Factors: Physiological Relevance
To determine whether nucleotides inhibit the CC-initiated
apoptosis in vivo, we first microinjected CC into the cyto-
plasm of various cells to mimic CC release induced by
apoptotic stimuli. Microinjection of CC (note that micro-
injected solutions generally get diluted 100-fold in the
Figure 4. Nucleotides Inhibit Apaf-1 Oligomerization and Caspase-9 Activation
(A) Far Western blotting. PVDF membranes with immobilized recombinant Apaf-1 or BSA were incubated with CC (1 mM) alone or CC plus ATP (0.5 or
5 mM), and then Western blotting was performed for CC (Cyt. C; upper panel). Shown in the lower panel is the Coomassie blue-stained gel image.
(B) IVT, 35S-labeled, procaspase-9 (C9) was incubated with Apaf-1 (A) plus CC (lane 1) or C9 plus Apaf-1 plus CC in the presence of 0.5 mM dATP
alone (lane 2) or dATP together with various amounts of ADP-R (ADP-ribose, lanes 3–6), c-ADP-R (cyclic ADP-ribose, lanes 7–10), dADP (lanes
12–14), ADP (lanes 15 and 16), 8-Cl-ATP (lanes 17 and 18), or 8-NH2-ATP (lanes 19 and 20). Shown is the autoradiography.
(C) IVT, 35S-labeled, procaspase-9 (C9) was incubated alone (lane 1) or with recombinant Apaf-1 (A; lane 2), or Apaf-1 plus CC (lane 3), or Apaf-1 plus
CC in the presence of dATP (lanes 4–8), ATP (lanes 9–12), dGTP (1 mM, lane 13), GTP (1 mM, lane 18), or dATP (0.5 mM) together with various amounts
of dGTP (lanes 14–17) or GTP (lanes 19–22) in a final volume of 20 ml of oligomerization buffer.
(D) Apaf-1 (10 nM) alone (top), Apaf-1 plus CC and 0.5 mM ATP (middle), or Apaf-1 plus CC and 5 mM ATP were incubated in 300 ml of oligomerization
buffer. The reaction mixture was fractionated using Superose 6 FPLC column, and aliquots of 20 ml of each fraction were used in Western blotting for
Apaf-1.Cell 125, 1333–1346, June 30, 2006 ª2006 Elsevier Inc. 1339
Figure 5. Direct Binding of ATP to CC
MALDI-MS spectra of CC (A); CC plus ATP at 10mM (B), 100mM (C), 500mM (D), or 2 mM (E); CC plus 2 mM ADP (G) or 2 mM AMP (H). CC alone or CC with
various nucleotides was coincubated, spotted on MALDI target, and spectra were acquired. The CC peak is at 12,231 and the other labeled peaks rep-
resent CC bound with different numbers of ATP molecules (B–E). In (G), one molecule of ADP (428 Da) showed weak binding to CC (i.e., the peak at
12,659). (F) Modeling of potential ATP binding sites on CC using RasMol software (v2.6)based on PDB file 1HRC. The CC is depicted as helix-and-strand
structure with ATP binding residues as space-filled balls. Of the 11 lysine residues (the aa numbers indicated) identified (Table S1), four (i.e., K7, K25,
K39, and K72) previously implicated in CC binding to Apaf-1 are indicated in red and the other seven in green. The yellow structure is the heme group. (I)
IVT-C9 was incubated with Apaf-1 plus CC with or without various amounts of ATP (lanes 2–5). In lanes 6–8, CC was preincubated with 0–5 mM of ATP
for 30 min at 37ºC and then unbound ATP was dialyzed out (overnight). Finally, the ATP bound CC was used in the reconstitution experiments.cytoplasm; Zhou et al., 2000) into PC3 (Figure S5A) or
GM701 (Figure S5B) cells induced dose- and time-depen-
dent apoptosis. Apoptotic cells showed typical blebbing1340 Cell 125, 1333–1346, June 30, 2006 ª2006 Elsevier Inc.cell morphology (Figure S5Cb, arrows) or compromised
plasma membrane integrity, allowing live cell nuclei
stained by DAPI (Figures S5Cc and S5Cd, arrowheads;
Figure 6. Nucleotides Inhibit CC-Initiated Cell Death and NTP Reduction Accompanies Caspase Activation
(A and B) PC3 cells were injected with CC (3 mg/ml stock) alone or CC plus ATP (100 mM stock) or dATP (1 mM stock) (A) or with CC plus dNTPs (1 mM
stock each) or plus NTPs or ADP (100 mM stock each) (B).
(C) Cells were microinjected with CC plus dNTP (10 mM stock) or NTP (100 mM stock) pools.
(D) Fresh GM701 cytosol was incubated alone (lane 1) or with different amounts of CC in the presence of 2 or 3 mM ATP. At the end, Western blotting
for caspase-9 and 3 was performed.
(E) PC3 cells were microinjected with CC (either 3 mg/ml or 40 mg/ml stock) plus dATP (1 mM stock), ATP (10 mM stock), or dNTP (1 mM) or NTP (40
mM) pools. Apoptosis (%) in (A), (B), (C), and (E) was determined as described in Experimental Procedures.
(F and G) GM701 (F) or MDA-MB231 (MDA; G) cells were treated with STS (0.5 mM) for the time intervals indicated. At the end, cells were harvested for
Western for caspase-3 and DEVDase assays (insets) as well as NTP measurements by HPLC. All data represent the mean ± SD of two independent
experiments.Chandra et al., 2002). Some dead cells lost the coinjected
Texas red dye (Figure S5Cd, arrows). Cell death induced
by the microinjected CC was Apaf-1 dependent as
apoptosis was diminished in Apaf-1-deficient SKOV-3
cells or Apaf-1/ MEFs (Figure S5D). We then coinjected
CC (3 mg/ml stock; final intracellular concentration
30 mg/ml) and various nucleotides into cells. Coinjection
of dATP (1 mM stock; [10 mM]) or ATP (100 mM stock;
[1 mM]) in PC3 (Figure 6A) or GM701 (Figure S5E) cells
strongly inhibited the CC-induced cell death. Other
NTPs or dNTPs coinjected into the PC3 cells also inhibited
the CC-induced apoptosis (Figure 6B). Coinjection of
dNTP ([10 mM]) or NTP ([1 mM]) pools into PC3,
GM701, HeLa, MDA-MB231, and HMEC (Figure 6C) cells
also inhibited the CC-induced cell death.
If physiological levels of nucleotide pools exert such
a dominant inhibitory effect on the CC-initiated apopto-
some formation and caspase activation, how then do
the stimulated cells die? One possibility is that persistent
apoptotic stimulation might result in increasing CC releasefrom the mitochondria, which would help to overcome the
inhibitory effects of nucleotides. This possibility is partially
supported by our demonstration that increasing amounts
of microinjected CC induces more cell death (Figures S5A
and S5B). To further test this possibility, we carried out
cell-free reconstitution experiments by incubating fresh
GM701 cell cytosol with an increasing amount of CC in
the presence of 0, 2, 3, or 5 mM ATP. We found that in
the absence of exogenous ATP, addition of increasing
amounts of CC led to correspondingly increased cas-
pase-9 and -3 processing (Figure 6D, lanes 2–8). In the
presence of 2–5 mM of ATP, caspase processing initiated
by lower levels of CC (2–10 mg/ml) was inhibited, as
evidenced by the levels of procaspase-9 bands and
decreased levels of the processed caspase-9 and -3 frag-
ments (Figure 6D; data not shown). However, higher con-
centrations of CC could partially overcome the inhibitory
effects of ATP at 2–5 mM, as evidenced by increased
apoptosome-derived p35 (Figure 6D; data not shown).
Similarly, microinjection of higher amounts of CC to theCell 125, 1333–1346, June 30, 2006 ª2006 Elsevier Inc. 1341
cells diminished the protective potential of coinjected nu-
cleotides (Figure 6E).
Another possibility is that during apoptosis, the levels of
(d)NTP pools, in particular, the ATP levels, might decline to
allow CC to bind to Apaf-1. To directly test this possibility,
we first measured the levels of ATP (and other NTPs) in
several apoptotic systems. We observed that in GM701
cells treated with staurosporine (STS, staurosporine,
a widely used kinase inhibitor that triggers intrinsic death
pathway), caspase activation was directly correlated
with prominent reductions in the levels of ATP (Figures
6F and S6A). In fact, there was a time-dependent de-
crease in the intracellular ATP levels and a corresponding
increase in caspase activation (Figures 6F and S6A). Im-
portantly, not only ATP levels but also other NTPs showed
a time-dependent decrease (Figures 6F and S6A). Similar
correlations between the decline in ATP (and NTP) levels
and caspase activation were observed in the following:
MDA-MB231 (Figures 6G and S6B) or LNCaP
(Figure S6C) cells treated with STS, MDA-MB231 cells
treated with etoposide (VP16; Figure S6D), multiple cell
types treated with the BMD compound (Figure S6E), a mi-
tochondrial toxin that upregulates the mitochondrial activ-
ities and triggers CC release (Chandra et al., 2002), and
HCT116 colon cancer cells treated with STS, Fas, and eto-
poside (Figure S6F). Decrease in ATP/NTP level early dur-
ing apoptosis induction was not a consequence of cas-
pase activation as z-VAD-FMK, a pan-caspase inhibitor,
did not show any inhibitory effect (Table S3).
We then further tested the hypothesis that as the apo-
ptotic process goes on, the levels of nucleotides bound
to CC will also decrease in vivo to allow CC binding to
Apaf-1. As shown in Figures S7A and S7B, STS induced
a time-dependent release of CC into the cytosol of
GM701 cells, and the nucleotide measurement of immu-
noprecipitated CC from the cytosols clearly demonstrated
significantly reduced levels of bound ATP and NTP during
apoptosis. A representative chromatogram is shown in
Figure S7C. Similar decreases in ATP/NTP levels bound
to CC were also observed in LNCaP cells stimulated
with doxorubicin (data not shown).
If apoptotic stimulation induces a reduction in the intra-
cellular NTP pools as well as in nucleotides bound to CC,
which in turn contributes to the apoptotic process, exog-
enously introduced nucleotides should then inhibit the ap-
optotic stimuli-induced cell death. We observed that after
16 hr of BMD or STS treatment of PC3 cells, 60% sur-
rounding uninjected cells underwent apoptosis whereas
only 20% of the cells preinjected with (d)ATP showed
apoptotic morphology (Figures 7A and 7B; data not
shown). (d)ATP similarly inhibited the BMD-induced
GM701 cell death (Figures 7A and 7B; data not shown).
Many control (i.e., uninjected) PC3 cells treated with STS
for 16 hr showed condensed or fragmented nuclei (Fig-
ure 7Bc, arrows) whereas most ATP-injected cells (Fig-
ure 7Bb, red) showed background-level DAPI staining
and normal nuclei. Similarly, many GM701 cells treated
with BMD for 4 hr became DAPI positive, whereas the ma-1342 Cell 125, 1333–1346, June 30, 2006 ª2006 Elsevier Inc.jority of the ATP-injected cells were DAPI negative (Fig-
ures 7Be–7Bh). Importantly, microinjection of nucleotides
did not inhibit the apoptotic stimuli-induced CC release
(Figure S8), supporting that nucleotides exert their apo-
ptosis-inhibitory effects downstream of CC release.
Finally, we carried out the reciprocal loss-of-function
experiments. We used 2-deoxyglucose (DG) or DG plus
sodium azide to first reduce the intracellular ATP and other
NTPs (Figure 7C and Table S4) and then microinjected
cells with low amounts of CC (i.e., 0.001 mg/ml stock;
[0.01 mg/ml]), which by themselves did not induce appre-
ciable cell death within 2 hr (Figures 7D and S9). Pretreat-
ment with DG or DG plus azide reduced not only ATP but
also, significantly, UTP (uridine triphosphate) and CTP (cy-
tidine triphosphate) levels (Figure 7C). The DG plus azide
treatment for 2 hr led to a reduction in total NTP concen-
trations by 50% (Table S4) or 60% (Figure 7C). Strik-
ingly, even 30% reduction in cellular NTP levels by DG
treatment alone (Figure 7C) rendered the cells much
more susceptible to apoptosis induction by the low levels
of microinjected CC (Figures 7D and S9). Interestingly, the
DG plus azide treatment, which demonstrated a more
potent ‘‘depleting’’ effect than DG alone (Figure 7C), also
sensitized more cell death than DG (Figure 7D). Impor-
tantly, the CC-initiated cell death sensitized by NTP
‘‘depletion’’ was inhibited by either coinjection of ATP or
refreshing cells in regular culture medium (Figures 7D
and S9) with medium replenishment providing a more
dramatic protective effect than ATP (Figure 7D), likely
because the replenishment restored not only ATP but
also other NTP levels (Figure 7C).
Some of the ATP might be hydrolyzed to ADP, which
also demonstrates some inhibitory effect on the CC-initi-
ated Apaf-1 activation (Figure 1H). Therefore, accompany-
ing decreased ATP levels might be significant increases in
ADP levels, which conceptually might neutralize the effect
of the decreased ATP and other nucleotides. To exclude
this possibility, we simultaneously measured ATP as well
as other NTP concentrations together with ADP levels in
the same set of samples, using the above-mentioned DG
plus azide as a positive control. As shown in Table S4,
DG plus azide treatment decreased both ATP and ADP
levels by 40%. Treatment of GM701 or MDA-MB231
cells with STS for 1 or 8 hr, respectively, when minimal cas-
pase activation occurred (see Figures 6F and FG), reduced
the levels of ATP and other NTPs (Table S4). There was
a slight increase in the ADP levels (Table S4). However,
compared with the decreases of NTP pools the marginal
increases in ADP were negligible. Indeed, the combined
concentrations of NTPs plus ADP in STS-treated GM701
or MDA-MB231 cells decreased by 60% and 45%, re-
spectively (Table S4), which should be sufficient to sensi-
tize cells to apoptosis induction (see Figures 7C and 7D).
Discussion
During the stress-induced cell death pathway, CC release
from the mitochondria represents the key initiating event
that eventually leads to caspase activation and demise
Figure 7. Nucleotides Regulate Apopto-
sis In Vivo
(A) PC3 or GM701 cells were preinjected with
dATP (10 mM stock) or ATP (100 mM stock)
followed by treatment with BMD (10 mM) or
STS (0.5 mM) 30 min later. Apoptotic cells
were counted in injected and surrounding cells
16 hr (PC3 cells) or 4 hr (GM701 cells) after
treatment.
(B) Representative microphotographs illustrat-
ing the protective effects of microinjected (MI)
ATP on PC3 cells treated with STS (0.5 mM 3
16 hr; a–d) or GM701 (GM) cells treated with
BMD188 (10 mM 3 4 hr; e–h). The arrows in
(c) point to cells showing condensed or frag-
mented nuclei (3200).
(C) PC3 cells were treated with either 2-deoxy-
glucose (DG, 10 mM) or DG plus azide (10 mM)
for either 30 min or 2 hr. Alternatively, cells were
treated with DG or DG plus azide for 2 hr
followed by replenishment of fresh medium
(med) for 1 hr. At the end, cells were harvested
for NTP measurements. Shown are the mean
values from duplicate experiments. The num-
bers in the parentheses are the percentages
of control samples (none).
(D) PC3 cells were injected with suboptimal
amounts of CC (0.001 mg/ml stock) alone or
CC plus ATP (80 mM stock). Alternatively,
PC3 cells were pretreated either with DG or
DG plus azide for 1 hr followed by microinjec-
tion of CC alone or CC plus ATP or with DG
for 1 hr followed by replenishment of fresh
medium for 1 hr followed by CC microinjection.
Shown are percentages of apoptosis (mean ±
SD) of two independent experiments. See Fig-
ure S9 for representative images.of the cell. Nevertheless, it has also become clear that
there exist postmitochondrial ‘‘barriers’’ in the cytoplasm
that can inhibit the CC-initiated apoptotic process, the
best known of which include intracellular ions (K+ and
Na+) that directly inhibit apoptosome formation (Cain
et al., 2001) and IAPs that inhibit the activities of the
apoptosome-activated caspases (Shi, 2004). Here we
show intracellular nucleotide pools as yet another class
of molecules that can directly block the CC-initiated apop-
tosome formation and caspase activation.
Reconstitution experiments using recombinant proteins
have established a requirement for dATP (1–10 mM) or
ATP (10–100 mM) in the CC/Apaf-1-mediated caspase ac-
tivation in vitro (Jiang and Wang, 2000; Riedl et al., 2005),which is confirmed in our own studies. Most cell-free ex-
periments also utilize (d)ATP together with CC to initiate
caspase activation. However, we find that, using cytosols
freshly prepared from approximately ten different cell
types, CC initiates robust caspase activation without re-
quiring exogenous (d)ATP. The diluted cytosol used in
our cell-free experiments contains 100 mM ATP (D.C.
et al., unpublished data), which should be sufficient for
the CC-induced caspase activation. One reason for the re-
quirement of exogenous (d)ATP in others’ cell-free exper-
iments could be due to the use of stored samples, in which
nucleotides may have been degraded.
The concentrations of dNTPs and NTPs in mammalian
cells are 20–500 mM and 3–10 mM, respectively (CraigCell 125, 1333–1346, June 30, 2006 ª2006 Elsevier Inc. 1343
and Wallace, 1991; Miller and Horowitz, 1986; Mesner
et al., 1999; Oliver et al., 1997; this study). The concentra-
tions of some NDPs and nucleotide intermediates are also
in the mM range (e.g., ADP and NAD levels can be up to
0.5 and 1 mM, respectively [Paschen et al., 2000; Seto
et al., 1985; this study]). Therefore, our results suggest
that nucleotides, nucleotide intermediates, and other
related metabolic intermediates, combined, would pose
a formidable ‘‘brake’’ on the CC-initiated apoptosome for-
mation and subsequent caspase activation. In support,
microinjected nucleotides inhibit apoptosis induced by
CC as well as intrinsic death stimuli and extend cell sur-
vival. More importantly, experimentally reducing the
ATP/NTP levels greatly sensitizes cells to the CC-initiated
apoptosis. These ‘‘gain-of-function’’ and ‘‘loss-of-func-
tion’’ experiments thus concretely establish that intra-
cellular nucleotides function as critical cellular survival
factors in vivo. The proposal that endogenous nucleotides
function as critical prosurvival factors is also supported by
numerous experimental observations. In yeast, increased
dNTP levels dramatically promote cell survival in response
to DNA damage (Chabes et al., 2003). Cellular nucleotide
pools are required not only for T-lymphocyte proliferation
but also for their survival (Quemeneur et al., 2003). Nucle-
otide intermediate such as NADPH has recently been
linked to oocyte survival (Nutt et al., 2005). Similarly,
increasing dNTP levels by overexpression of thymidine
kinase (involved in de novo synthesis of dNTPs) or ribonu-
cleotide reductase (RNR) (Grusch et al., 2001; Oliver et al.,
1997), as well as by supplementing cells with nucleotide
precursors, confers resistance to apoptosis (Kelly et al.,
2001). Also, cancer cell death induced by commonly
used chemotherapeutic drugs such as methotrexate and
cis-platinum are mediated by drug-induced decreases of
dNTP pools (Wang et al., 2005).
How do physiological levels of nucleotides inhibit the
CC-initiated apoptosome formation? Our results provide
convincing evidence that high concentrations of nucleo-
tides directly interfere with CC binding to Apaf-1, the
most upstream event in the CC-initiated apoptosome
formation. The inhibitory effects of nucleotides and nu-
cleotide intermediates seem to be related to the negative
charges they carry. Hence, (d)NTPs, (d)NDPs, and
(d)NMPs have four, three, and two negative charges,
respectively, and they demonstrate an inhibitory effect in
the order of (d)NTPs > (d)NDPs > (d)NMPs. NADP carries
an extra negative charge compared to NAD and corre-
spondingly shows a stronger inhibitory effect. Nucleotide
analogs are also charged and are effective in inhibiting
CC-induced caspase activation, whereas their uncharged
nucleoside counterparts are without effect. These obser-
vations suggest that nucleotides may directly bind CC
through electrostatic interactions. Indeed, the abilities of
the nucleotides to bind to CC correlate well with the nega-
tive charges they carry (ATP > ADP > AMP).
Significantly, the ability of nucleotides to bind to CC
also correlates well with their inhibitory effect on the CC-
initiated caspase activation, suggesting that nucleotide1344 Cell 125, 1333–1346, June 30, 2006 ª2006 Elsevier Inc.binding to CC may mask sites on CC that are essential
for its interaction with Apaf-1. CC interaction with Apaf-1
has been shown to be electrostatic and is mediated by
the binding of multiple lysine residues on CC, including
K7, K25, K39, and K72 to negatively charged aspartate
residues in the Apaf-1 WD-40 domain (Purring-Koch and
McLendon 2000; Yu et al., 2001). The critical role of the
CC K72 residue in CC-Apaf-1 interaction and caspase
activation is highlighted by recent in vivo studies (Hao
et al., 2005). Our current study also implicates five other
K residues (i.e., K8, K13, K86, K87, and K88) in mediating
CC binding to Apaf-1 as the CC proteins with these sites
mutated fail to activate Apaf-1-mediated caspase-9
activation.
How could cells override the barrier imposed by the
intracellular nucleotides and their derivatives so that
apoptosis can proceed? At least two mechanisms may
cooperate to overcome the nucleotide barrier. First, per-
sistent apoptotic stimulation may result in increased CC
release resulting in increased caspase activation and cell
death, as supported by our reconstitution and microinjec-
tion experiments using increasing amounts of CC. Our ob-
servations (D.C. and D.T., unpublished data), along with
others’ (Waterhouse et al., 2001), suggest that cells
contain 5–150 mM CC that can be released from the mito-
chondria during apoptotic stimulation, which might be
sufficient to overwhelm the inhibitory effect of the nucleo-
tides. Second, the ‘‘brake’’ deactivates by itself, i.e.,
apoptotic stimulation results in a decrease in intracellular
nucleotide pools. Cell death induced by many other stim-
uli, such as cytokine withdrawal, chemicals, chemothera-
peutic drugs, and ischemic injury, is also accompanied by
a decrease in multiple nucleotides (Dagher, 2000; Grusch
et al., 2001; Kelly et al., 2001; Oliver et al., 1997; Wang
et al., 2005). Moreover, during apoptotic stimulation, nu-
cleotides may undergo distributional changes (Miller and
Horowitz, 1986) or leak out of cells due to partially com-
promised membrane integrity. All of these could conceiv-
ably contribute to an overall decrease in the intracellular
nucleotide pools.
Our model predicts that when small amounts of CC ac-
cidentally ‘‘leak’’ out of the mitochondria in normal cells or
when small amounts of CC are released from the organelle
early during apoptotic stimulation, the CC released into
the cytosol shall be bound (or modified) by ATP as well
as other nucleotide species, thus preventing it from inter-
acting with Apaf-1. However, in the persistent presence of
apoptotic stimulation and mitochondrial damage, in-
creased CC release, together with decreases (or alter-
ations) of nucleotides and their intermediates, would result
in the removal of the ‘‘nucleotide brake’’ and activation of
the Apaf-1 apoptosome. The concerted actions of these
two mechanisms suggest that when CC release reaches
a certain threshold and nucleotides decrease to a certain
level, the existing nucleotides will no longer be sufficient to
block CC interaction with Apaf-1, thus allowing Apaf-1
oligomerization and apoptosome assembly to occur.
This model potentially reconciles the apparent paradox
in which high levels of nucleotides inhibit while lower levels
of (d)ATP activate the apoptosome. It should be pointed
out, however, that the demonstrated requirements for
low levels of (d)ATP in the CC-initiated apoptosome for-
mation are, to our knowledge, all based on in vitro cell-
free or recombinant protein reconstitution experiments,
and the precise roles of (d)ATP in apoptosome activation
in the cells remain yet to be determined. Since the NTP
levels are significantly higher than those of dNTPs, our re-
sults suggest that NTPs (particularly ATP) probably play
a more prominent role in regulating both cell survival and
death. The key role of CC in ATP synthesis ensures a bal-
ance between its metabolic (antiapoptotic) and proapop-
totic roles. This may provide a mechanism that protects
cells from inappropriate CC release from mitochondria.
Regardless, our observations, together with recent stud-
ies showing that ATP atR1 mM also negatively regulates
caspase-9 through direct binding (Chereau et al., 2005)
and that apoptosome formation appears to require dATP
hydrolysis and nucleotide exchange on Apaf-1 (Kim
et al., 2005), suggest that the functions of nucleotides in
regulating apoptosome formation and caspase activation
in vivo are more complicated than we previously consid-
ered. Finally, our results provide both mechanistic insights
on the cell-killing effects of many anticancer drugs and an
exploratory foundation to help design novel, and in partic-
ular, nucleotide-based, antineoplastic agents.
EXPERIMENTAL PROCEDURES
Cell-Free Reconstitution
All cell-free reactions were performed in homogenizing buffer in a total
volume of 100 ml (Chandra and Tang, 2003). Briefly, cytosols were
activated by adding bovine CC (15 mg/ml) with or without (d)ATP and
incubated for 150 min at 37ºC. In some experiments, cytosols were
activated in the presence of various nucleotides and salts. In others,
either XIAP-immunodepleted cytosol or recombinant purified Smac
was added in the reaction mixture. After incubation samples were
either used for substrate cleavage assays for caspase-9 (LEHDase)
and caspase-3 (DEVDase) or caspase cleavage by Western blotting.
Alternatively, purified Apaf-1XL was incubated with IVT, 35S-labeled
procaspase-9 (TNT T7 Quick; Promega) with CC (1 mM) in the presence
of nucleotides for 60 min at 30ºC in oligomerization buffer. After incu-
bation, the sample buffer was added and proteins resolved by SDS-
PAGE followed by autoradiography.
Analysis of Apoptosome Complexes
Control, CC-activated, or CC/dATP-activated cytosols were fraction-
ated by size-exclusion chromatography using Superose 6 HR 10/30
column (Amersham Pharmacia Biotech). Apoptosome complexes
(700 kDa) were eluted using column buffer (20 mM HEPES, 0.1%
(w/v) CHAPS, 5 mM DTT, 5% (w/v) sucrose pH 7.0) supplemented
with 50 mM NaCl. Different fractions were then analyzed by Western
blotting for changes in the distribution of Apaf-1 and processing of
caspase-3 and -9 (Cain et al., 2000).
Microinjection
Cell microinjection was performed in 6 cm tissue culture dish using an
Eppendorf pressure injector (model 5246) and micromanipulator
model (model 5171). Microinjection needles (inner diameter,
0.1 mm) were purchased from Eppendorf and loaded using Eppen-
dorf microloaders. Dextran-Texas red (MW 10,000 lysine fixable,Molecular Probes; 0.2% final concentration) with different combina-
tions of CC and nucleotides was injected into the cytoplasm of various
cells (pressure, 40–80 hPa; time, 0.3 s). Immediately after injection,
cells were replenished with fresh medium. An average of 100–150 cells
were microinjected for each condition and injected cells were scored
for apoptosis based on morphology and DAPI staining (Chandra
et al., 2002).
Details for cells; reagents, basic apoptosis protocols, Far Western
blotting, immunoprecipitation, site-specific mutagenesis of CC, ex-
pression and purifications of proteins, CC modifications by MALDI-
MS and sites of CC modifications, and the determination of NTP and
dNTP levels are provided in Supplemental Experimental Procedures.
Supplemental Data
Supplemental Data include nine figures, four tables, and Supplemental
Experimental Procedures (SEP) and can be found with this article on-
line at http://www.cell.com/cgi/content/full/125/7/1333/DC1/.
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